⌘K

Login Start Free

Home/Filings/4/0001209191-17-005572

4//SEC Filing

Kura Oncology, Inc. 4

Accession 0001209191-17-005572

$KURACIK 0001422143operating

View on SEC.gov Company Profile

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 5:35 PM ET

Size

5.4 KB

Accession

0001209191-17-005572

Insider Transaction Report

Form 4

Period: 2017-01-23

Kura Oncology, Inc.KURA

Chief Scientific Officer

Transactions

Award
Option to purchase common stock
2017-01-23+63,000→ 63,000 total
Exercise: $6.15Exp: 2027-01-22→ Common Stock (63,000 underlying)

Footnotes (1)

[F1]This option vests in 48 equal monthly installments commencing on the grant date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001422143

Filing Metadata

Form type: 4
Filed: Jan 24, 7:00 PM ET
Accepted: Jan 25, 5:35 PM ET
Size: 5.4 KB

View on SEC.gov